Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00247806
Status:
TERMINATED
Last Update Posted:
2008-09-25
First Post:
2005-10-31
Brief Title:
Prevalence of Lactose Intolerance Following Stem Cell Transplantation
Sponsor:
University of British Columbia
Organization:
University of British Columbia
Study Overview
Official Title:
Prevalence of Lactose Intolerance Following Stem Cell Transplantation in Pediatric Patients
Status:
TERMINATED
Status Verified Date:
2005-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Too few patients completed the study once enrolled
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
It is currently assumed that all patients are lactose intolerant post bone marrow transplantation This pilot study is to assess what the incidence of lactose intolerance is after bone marrow transplantation in children This will be done using a lactose breath test
Detailed Description:
All pediatric patients over the age of 4 years who are scheduled for a stem cell transplant will be approached to assess whether what the incidence of lactose intolerance is in the post transplant period and how quickly recovery occurs A baseline lactose and lactulose breath test will be performed followed by repeat lactose breath tests starting 2 weeks after day 0 and repeated every fortnight for 10 weeks Stool pH and reducing substances will be checked at the time of the breath tests to see if there is any correlation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None